Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes

Completed · Phase 3 · Has a placebo group

Conditions studied: Type 2 Diabetes, Nonalcoholic Fatty Liver Disease, Vitamin D Deficiency

In brief

This study is designed to study the effect of vitamin D intake on the severity of fatty liver and poor glucose control in patients with type 2 diabetes and fatty liver disease.

Key facts

Study ID

NCT02132442

Run by

University of Massachusetts, Worcester

People needed

12

Starts

2014-03-01

Expected to finish

2016-10-01

Last updated by the study team

2017-01-10

Who can join

Age: 10 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children: 10 - 17 years
• Adults: 18 - 50 years
• Type 2 diabetes > 6 mo duration
• 25-hydroxyvitamin D [25(OH)D] level of <20 ng/mL
• Hepatic triglyceride content (HTGC) value of >5.6%
• HbA1c of > 8%;
• Ability to take medication by mouth.

You may not qualify if…

• Pregnant or lactating women
• Mental deficiency (IQ <70)
• Chronic liver disease
• Disorders of vitamin D metabolism, kidney, or parathyroid disease;
• Calcium and/or vitamin D supplementation
• Mauriac syndrome
• Malabsorption of fat soluble vitamins
• Drug toxicity and alcoholism

Where it is running

• University of Massachusetts Medical School — Worcester, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.